FERMT2 and breast cancer: Importantly, in the Kindlin-2-deficient cancer cells, the binding of p53 to the promoters of SerpinB2 and p21 was significantly enhanced, thereby identifying a novel role of Kindlin-2 in the regulation of BC progression and metastasis.